BioMarin (United States)
In research, BioMarin (United States) stands highest in Health Sciences (#11,929 of 20,462 worldwide), Life Sciences (#9,146 of 14,347 worldwide) and Medicine (#14,211 of 17,978 worldwide), over all time. Relative to its size it is most specialised in Biochemistry, Genetics and Molecular Biology — Biochemistry, Genetics and Molecular Biology is 7.7× its share of world research.
- World rank, 2022–2025
- #19,193 of 28,054 · #17,492 all time
- Rank in United States
- #2,786 of 4,192
- Research works
- 341 ◆ 2% vs 2013–17
- Citations
- 9.6k 28.2 per fractional work
- Top-10% rate
- 18.3% record average 16.5%
- Open access
- 48% world 28%
What is BioMarin (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #11,929 of 20,462 | 20.9% | 150 | |
| Life SciencesDomain | #9,146 of 14,347 | 22.7% | 136 | |
| MedicineField | #14,211 of 17,978 | 20.4% | 146 |
Each strip is that field’s whole ranked pool, with the notch where BioMarin (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does BioMarin (United States) specialise in?
Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 7.7× the share of its output that it takes of world research.
- Biochemistry, Genetics and Molecular BiologyField · 28.1 works7.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.7×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 7.7×
- Pharmacology, Toxicology and Pharmaceutics 3.4×
- Medicine 2.2×
- Immunology and Microbiology 1.5×
- Veterinary 1.2×
- Neuroscience 0.7×
- Chemistry 0.6×
- Economics, Econometrics and Finance 0.5×
- Agricultural and Biological Sciences 0.4×
- Nursing 0.3×
- Environmental Science 0.3×
- Mathematics 0.2×
- Business, Management and Accounting 0.2×
- Social Sciences 0.2×
- Decision Sciences 0.2×
- Physics and Astronomy 0.2×
- Health Professions 0.2×
- Engineering 0.1×
- Psychology 0.1×
- Materials Science 0.1×
- Computer Science 0.1×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at BioMarin (United States)?
Ranked on the composite score, Stuart Bunting, Qingqi Chen and Anita Grover lead among researchers whose main affiliation is BioMarin (United States).
- 1 Stuart Bunting United States · #115,967 worldwide 537 citations · 21 works
- 2 Qingqi Chen United States · #993,789 worldwide 76 citations · 16 works
- 3 Anita Grover United States · #1,629,980 worldwide 6 citations · 15 works
Which keywords describe research at BioMarin (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Gene Therapy, Factor VIII, Hemophilia, Genomic Integration, AAV, Viral Vectors, Metabolic Disorders and Newborn Screening.
- Trypanosoma cruzi
- Thrombosis
- Marfan Syndrome
- Ehlers-Danlos Syndrome
- Cell Culture
- Genetic Mutations
- Metabolism
- Biopharmaceutical Production
- RNA-Guided
- Lysosomal Storage Disorders
- Chimeric Antigen Receptor
- Cancer Immunotherapy
- Skeletal Muscle Atrophy
- Stem Cells
- Carnitine
- Newborn Screening
- Epidemiology
- Viral Vectors
- Genomic Integration
- Factor VIII
- Gene Therapy
- Hemophilia
- AAV
- Inflammation
- Metabolic Disorders
- Biochemical Genetics
- Mitochondrial Function
- Muscle Regeneration
- Immunotherapy
- CAR T Cells
- Enzyme Replacement Therapy
- Genome Engineering
- Metabolic Syndrome
- Glycosylation
- Neurological Disorders
- Hemostasis
- Drug Resistance
- Mammalian Cells
- Recombinant Protein
- Chagas Disease
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Gene Therapy12▲ 93×4 topics
- Factor VIII6▲ 626×1 topic
- Hemophilia6▲ 626×1 topic
- Genomic Integration5▲ 131×2 topics
- AAV5▲ 178×1 topic
- Viral Vectors5▲ 178×1 topic
- Inflammation4▲ 3.1×18 topics
- Epidemiology4▲ 1.37×16 topics
- Metabolic Disorders4▲ 46×2 topics
- Newborn Screening4▲ 98×2 topics
- Biochemical Genetics3▲ 140×1 topic
- Carnitine3▲ 140×1 topic
- Mitochondrial Function3▲ 53×3 topics
- Stem Cells3▲ 15×2 topics
- Muscle Regeneration2▲ 135×1 topic
- Skeletal Muscle Atrophy2▲ 135×1 topic
- Immunotherapy2▲ 4.6×3 topics
- Cancer Immunotherapy2▲ 21×3 topics
- CAR T Cells2▲ 42×1 topic
- Chimeric Antigen Receptor2▲ 42×1 topic
- Enzyme Replacement Therapy2▲ 169×1 topic
- Lysosomal Storage Disorders2▲ 205×1 topic
- Genome Engineering2▲ 46×1 topic
- RNA-Guided2▲ 46×1 topic
- Metabolic Syndrome2▲ 3.4×6 topics
- Biopharmaceutical Production2▲ 63×2 topics
- Glycosylation2▲ 22×3 topics
- Metabolism2▲ 4.8×4 topics
- Neurological Disorders2▲ 4.3×6 topics
- Genetic Mutations2▲ 5.3×5 topics
- Hemostasis2▲ 24×3 topics
- Cell Culture2▲ 20×2 topics
- Drug Resistance2▲ 7.8×2 topics
- Ehlers-Danlos Syndrome2▲ 106×1 topic
- Mammalian Cells2▲ 92×1 topic
- Marfan Syndrome2▲ 106×1 topic
- Recombinant Protein2▲ 92×1 topic
- Thrombosis2▲ 7.9×2 topics
- Chagas Disease1▲ 124×1 topic
- Trypanosoma cruzi1▲ 124×1 topic
Which research topics does BioMarin (United States) publish most on?
By volume in 2022–2025: Hemophilia Treatment and Research, Virus-based gene therapy research, Metabolism and Genetic Disorders and Muscle Physiology and Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemophilia Treatment and Research Hematology 6 works
- 2 Virus-based gene therapy research Genetics 5 works
- 3 Metabolism and Genetic Disorders Clinical Biochemistry 3 works
- 4 Muscle Physiology and Disorders Molecular Biology 2 works
- 5 CAR-T cell therapy research Oncology 2 works
- 6 Lysosomal Storage Disorders Research Physiology 2 works
- 7 CRISPR and Genetic Engineering Molecular Biology 2 works
- 8 Connective tissue disorders research Genetics 2 works
- 9 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
- 10 Trypanosoma species research and implications Epidemiology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has BioMarin (United States)'s research output changed?
Output in 2018–2022 was 2% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Rafael
- Center Point
- Dominican University of California
- Centerforce
- Kaiser Permanente San Rafael Medical Center
- PAX Scientific (United States)
- Marin Health and Human Services
- National Eczema Association
- Zero Breast Cancer
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.